Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 29, 2021 07:30 ET | Source: Ciclomed, LLC

CicloMed Announces Initiation of Phase 1B Trial of Fosciclopirox in Newly Diagnosed and Recurrent Urothelial Cancer Patients

KANSAS CITY, Mo., June 29, 2021 (GLOBE NEWSWIRE) -- CicloMed LLC., a Kansas City-based biotechnology company developing novel treatments for bladder cancer and other malignancies, today announced...